Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion type Assertion NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_head.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion description "[Furthermore, the CD33-redirected T cells were effective in vivo, preventing the development of leukemia after prophylactic administration and delaying the progression of established disease in mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_provenance.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion evidence source_evidence_literature NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_provenance.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion SIO_000772 25480499 NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_provenance.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion wasDerivedFrom befree-2016 NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_provenance.
- NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_assertion wasGeneratedBy ECO_0000203 NP1245338.RAHMgOds2xxQWzXdJSCUl4kCpy-u2YhmD2HKu7DlZRAbY130_provenance.